We believe that collaboration with industry, universities, hospitals and others plays an essential role in improving care for the patients we serve through research.
Citylabs is a partnership with Manchester Science Partnerships to provide accommodation to biomedical companies on our hospital site, plus access to clinical expertise to better understand market need and develop/trial new diagnostics and devices. Its success in providing stronger links between the NHS, academic health science communities and private sector businesses has resulted in the proposed development of Citylabs 2.0 and Citylabs 3.0 on our hospital site by 2021.
Manchester University NHS Foundation Trust sits in the heart of Corridor Manchester – Manchester’s cosmopolitan hub and world-class innovation district. Learn more about the benefits that our location brings here.
Greater Manchester Health and Social Care Devolution
Greater Manchester Health and Social Care Devolution (GMdevo). Since 1st April 2016, Greater Manchester is taking control of £6 billion of public funding for health and social care, providing unprecedented health and social change opportunity reaching out to an integrated network for 15 NHS hospitals, 14 NHS commissioning groups and 500 GP practices.
Health Innovation Manchester
Health Innovation Manchester is making the most of opportunities afforded through GMdevo to accelerate innovation and improve the health of Greater Manchester residents and beyond.
Manchester Academic Health Science Centre (MAHSC)
Together with The University of Manchester, we combine our expertise with that of five other local NHS Trusts through MAHSC. MAHSC is one of only five academic health science centres in England set up to interconnect existing research activity, to generate health benefits, economic development, enterprise, innovation and wealth creation.
Manchester Health Ventures (MHV)
Manchester Health Ventures, a wholly-owned company of Manchester University NHS Foundation Trust, manages and develops the Trust’s intellectual property assets.
Manchester Integrated Medicine and Innovative Technology (MIMIT)
MIMIT identifies unmet clinical needs, and provides access to funding and networks, in collaboration with TRUSTECH, to help for NHS staff identify/develop potential solutions.
Manchester Molecular Pathology Innovation Centre and Stoller Biomarker Discovery Centre
The Manchester Molecular Pathology Innovation Centre and co-located Stoller Biomarker Discovery Centre are creating molecular pathology tests to diagnose, pick the right treatment and assess the response to treatment for a range of inflammatory conditions including rheumatoid arthritis, lupus and psoriasis.
Manchester Science Partnerships
Central Manchester Hospitals is a shareholder and partners closely with Manchester Science Partnerships – the UK’s largest science park operator, supporting the growth of companies including across the life sciences, advanced engineering and ICT.
MedTech Centre Incubator
The MedTech Centre is an incubator (accommodation [hot desks/dry-laboratory facilities] and access to clinical expertise) for small companies and innovators developing technology, which will help the NHS to provide high-quality, efficient care to its patients. The MEDTECH Centre is partnership between Manchester Science Partnerships, Manchester University NHS Foundation Trust, and TRUSTECH, and proof of concept for Citylabs.
National Graphene Institute (NGI)
The £61m National Graphene Institute (NGI) is the national centre for graphene research in the UK, drawing in specialists from across the globe. It houses state-of-the-art cleanrooms, plus laser, optical, metrology and chemical labs and equipment – the ideal environment for world-class graphene research.
National Institute for Health Research Clinical Research Network: Greater Manchester (NIHR CRN:GM)
The NIHR CRN is the clinical research delivery arm of the NHS. The NIHR CRN: GM is hosted by Central Manchester University Hospitals NHS Foundation Trust. The host is responsible for ensuring the effective delivery of research in the Trusts, primary care organisations and other qualified NHS providers throughout the Greater Manchester area.
National Institute for Health Research (NIHR) Devices for Dignity
Central Manchester Hospitals partners with NIHR Devices for Dignity to develop innovative healthcare technologies that preserve dignity and promote independence for people living with long term conditions.
Based at BioHub at Alderley, NHS@BioHub brings the Manchester clinical-academic campus to Alderley Park, providing industry with access to clinical expertise, patients, and world-leading facilities. NHS@BioHub is delivered by Manchester University NHS Foundation Trust, in collaboration with NHS and academic organisations in the North.
Northern Health Science Alliance (NHSA)
NHSA is a partnership established by the leading Universities and NHS Hospital Trusts in the North of England to improve the health and wealth of the region by creating an internationally recognised life science and healthcare system.
The University of Manchester
The University of Manchester is our main research partners, and shares with us the largest-clinical academic campus in Europe.
TRUSTECH the North West NHS Innovation service provides innovation management, and industry engagement services to Trusts across the North West region, including Central Manchester Hospitals.